Precise Diagnosis for Precision Lung Cancer Drug: GE Healthcare’s Clarient Diagnostics Offering FDA approved PD-L1 companion diagnostic for Merck’s Keytruda®

California, USA – 2 October 2015 –  Clarient Diagnostic Services, Inc. a division of GE Healthcare (NYSE:GE) announced it will be offering the FDA approved PD-L1 companion diagnostic which will help identify patients most likely to benefit from Merck’s newly-approved lung cancer drug, Keytruda.   http://www.genewsroom.com/press-releases/precise-diagnosis-precision-lung-cancer-drug-ge-healthcare%E2%80%99s-clarient-diagnostics Read more

Temple University Health System and GE Healthcare Sign Innovative Value-Based Radiology Services Collaboration Agreement

PHILADELPHIA, PA – August 25, 2015 –  Academic medical centers across the U.S. are experiencing increasing pressure to enhance value – deliver higher quality at lower cost – as they continue to face challenges related to outcomes, cost control, market competition, and other dynamics.  Initiatives to promote value typically involve reimbursement arrangements between health insurers... Read more

New Publications Highlight Utility of Single Molecule, Real-Time Sequencing for Structural Variation Detection, Haplotype Reconstruction and De Novo Human Genome Assembly

MENLO PARK, Calif., July 13, 2015 (GLOBE NEWSWIRE) — A number of new scientific publications demonstrate the growing momentum for using Single Molecule, Real-Time (SMRT®) Sequencing to capture genetic variants that other technologies miss, according to Pacific Biosciences of California, Inc., (Nasdaq:PACB) provider of the PacBio® RS II Sequencing System. This has been demonstrated through... Read more

Press Release: METTLER TOLEDO’s Weighing Standard Ensures USP Compliance Free new interactive On-demand Webinar Clarifies the New Rules

United States Pharmacopeia (USP) published the revised mandatory Chapter 41 on balances as well as new updates to the advisory Chapter 1251. With just six months to comply, METTLER TOLEDO’s global weighing standard, GWP®, can help pharmaceutical manufacturers and suppliers to meet the new requirements. The new revisions define modified balance test procedures for the... Read more

Omnyx Receives FDA Clearance for Digital Manual Read of HER2 Pathology Slides

FDA clearance arms pathologists with digital technology to help assess treatment options for breast cancer patients PITTSBURGH — April 14, 2014 — GE Healthcare and UPMC today announced that the Omnyx™ Manual Read of the Digital HER2 Application has received 510(k) clearance from the U.S. Food and Drug Administration (FDA). This clearance will allow the... Read more

New Sievers M-Series TOC Analyzers

April 9, 2014 – Boulder, CO – GE Analytical Instruments introduces the Sievers M-Series TOC Analyzers. The M9, M9e and M5310 C Analyzers, including portable, laboratory, and on-line models, were developed using customer feedback. A new, 2-minute video, introduces the new analyzers, features, and the applications that benefit from the addition of Conductivity measurement, twice-as-fast analysis and dual-stream capabilites. Click here to view.... Read more

JEOL and Zoex Partnership Combines Comprehensive Two-Dimensional Gas Chromatography with High Sensitivity Mass Spectrometer

(Peabody, Mass. June 7, 2013) — JEOL USA, Inc. (Peabody, MA) has concluded an OEM agreement with Zoex Corporation (Houston, TX) to offer the Zoex comprehensive two-dimensional gas chromatography (GC x GC) technology with the new JEOL AccuTOF GCV 4G high-resolution time-of-flight mass spectrometer system.  “We are very excited about the partnership with Zoex. The... Read more